Keros Therapeutics logo
Keros Therapeutics KROS
$ 55.79 3.62%

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Keros Therapeutics P/B Ratio 2011-2024 | KROS

Annual P/B Ratio Keros Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
6.06 5.39 5.61 4.71 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
6.06 4.71 5.44